Literature DB >> 20496923

Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1.

Rajendra P Tanpure1, Tracy E Strecker, David J Chaplin, Bronwyn G Siim, Mary Lynn Trawick, Kevin G Pinney.   

Abstract

Synthetic routes have been established for the preparation of regio- and stereoisomerically pure samples of the mono-beta-d-glucuronic acid derivatives of combretastatin A-1, referred to as CA1G1 (5a) and CA1G2 (6a). Judicious choice of protecting groups for the catechol ring was required for the regiospecific introduction of the glucuronic acid moiety. The tosyl group proved advantageous in this regard. The two monoglucuronic acid analogues demonstrate low cytotoxicity (compared to CA1, 2) against selected human cancer cell lines, with CA1G1 being slightly more potent than CA1G2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20496923     DOI: 10.1021/np100108e

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  5 in total

1.  Regioselective synthesis of water-soluble monophosphate derivatives of combretastatin A-1.

Authors:  Rajendra P Tanpure; Benson L Nguyen; Tracy E Strecker; Savannah Aguirre; Suman Sharma; David J Chaplin; Bronwyn G Siim; Ernest Hamel; John W Lippert; George R Pettit; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Nat Prod       Date:  2011-06-30       Impact factor: 4.050

2.  Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.

Authors:  Laxman Devkota; Chen-Ming Lin; Tracy E Strecker; Yifan Wang; Justin K Tidmore; Zhi Chen; Rajsekhar Guddneppanavar; Christopher J Jelinek; Ramona Lopez; Li Liu; Ernest Hamel; Ralph P Mason; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2016-01-06       Impact factor: 3.641

3.  An Amino-Benzosuberene Analogue That Inhibits Tubulin Assembly and Demonstrates Remarkable Cytotoxicity.

Authors:  Rajendra P Tanpure; Clinton S George; Madhavi Sriram; Tracy E Strecker; Justin K Tidmore; Ernest Hamel; Amanda K Charlton-Sevcik; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2012-06       Impact factor: 3.597

4.  Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.

Authors:  Blake A Winn; Laxman Devkota; Bunnarack Kuch; Matthew T MacDonough; Tracy E Strecker; Yifan Wang; Zhe Shi; Jeni L Gerberich; Deboprosad Mondal; Alejandro J Ramirez; Ernest Hamel; David J Chaplin; Peter Davis; Ralph P Mason; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Nat Prod       Date:  2020-03-20       Impact factor: 4.050

5.  Synthesis and characterisation of (Z)-styrylbenzene derivatives as potential selective anticancer agents.

Authors:  Ya-Bing Xin; Jia-Jun Li; Hong-Jian Zhang; Jun Ma; Xin Liu; Guo-Hua Gong; Yu-Shun Tian
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.